Yishan Zhou | Cardiology | Most Reader’s Article Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Yishan Zhou | Cardiology | Most Reader's Article Award

The Seventh Clinical College of Guangzhou University of Chinese Medicine | China

Ms. Zhou Yishan is a dedicated researcher in Chinese Internal Medicine whose academic and professional journey reflects consistent excellence and a strong commitment to advancing integrative medical practice. She earned her Bachelor of Medicine in Clinical Medicine (Integrated Chinese and Western Medicine) from Guangzhou Medical University, followed by a Master of Medicine in Chinese Internal Medicine (Nephrology) from Guangzhou University of Chinese Medicine. During her postgraduate studies, she served as a core project member in the Sanming Project of Medicine in Shenzhen, contributing to research initiatives focused on clinical nephrology. She also played a key role in the Baoan District Association of Chinese Medicine Promotion Project, working on the clinical evaluation of the Yiqi Huoxue Fumigation-Wash formula for preventing early failure of autogenous arteriovenous fistulas, demonstrating her commitment to improving patient outcomes through evidence-based traditional therapies. Earlier in her academic career, she served as a Research Assistant at the National Center for Respiratory Medicine, supporting Professor Sun’s team through data collection, literature reviews, and preparation of research materials, which strengthened her multidisciplinary foundation. Her achievements have been recognized through honors such as Outstanding Graduate and University Merit Student, along with multiple First-Class and Second-Class Scholarships. With 2 published documents, 11 citations, and an h-index of 1, Ms. Zhou continues to build a promising research profile grounded in rigorous clinical investigation and integrative medical innovation.

Profile: Scopus

Featured Publications

Zhou, Y., Zou, Y., Cao, Y., et al. (2025). The association between the cardiometabolic index and hyperuricemia: 2011–2016 NHANES. Frontiers in Endocrinology, 16, 1545968.

Cao, Y., Zhou, Y., Zhong, Y., Liao, X., Chen, X., & Pi, Y. (2024). Association between oxidative balance score in adults with and without chronic kidney disease: 2011–2028 NHANES. Frontiers in Nutrition, 11, 1374719.

Zhou, Y., et al. (2025). Clinical observation on Yiqi Huoxue Fumigation-Wash Formula for preventing early failure of autogenous arteriovenous fistula. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 31(08), 114–120, 127.

Zhou, Y., et al. (2024). Exploration on the clinical application of Ephedrae Herba in stimulating Yang Qi. Journal of Guangzhou University of Traditional Chinese Medicine, 41(01), 234–239.

Getu Gizaw | Cardiovascular Researches | Editorial Board Member

Published on by Cardiology and Cardiovascular Medicine

Dr. Getu Gizaw | Cardiovascular Researches | Editorial Board Member

Jimma University | Ethiopia

Getu Gizaw is an Assistant Professor of Human Nutrition at Jimma University, Ethiopia, and a seasoned academic and researcher with extensive experience in maternal and child health, acute malnutrition management, and public health nutrition across humanitarian and development settings. With more than nine years of involvement in observational studies and randomized controlled trials, he has contributed significantly to evidence generation on the impacts of malnutrition and the effectiveness of simplified, community-based treatment approaches. He has played major roles in high-impact research, including a large UNICEF-supported randomized controlled trial evaluating cost-effective strategies for treating acute malnutrition, where he contributed to protocol development, data management, field coordination, staff supervision, training, and donor reporting. At Jimma University, he lectures on nutritional epidemiology, diet and disease, and emergency nutrition, supervises postgraduate students, and participates in institutional and national technical working groups focused on updating and adapting guidelines for wasting prevention and malnutrition management. Based in Addis Ababa, he also works as an independent consultant, specializing in study design, implementation research coordination, program monitoring and evaluation, and stakeholder engagement, supporting organizations in strengthening the quality and impact of public health and nutrition interventions. Skilled in advanced statistical analysis and widely published in peer-reviewed journals, he remains committed to advancing research-driven, context-appropriate solutions that improve maternal and child health outcomes and contribute to national and global nutrition agendas.

Profiles: Scopus | Orcid

Featured Publications:

Gizaw, G., Mekonnen, N., Mamo, A., Fekadie, A., Nigussie, S., G/Egziabher, M., Mekonin, W., Girma, S., Mulat, S., Mekonnen, A., et al. (2025). Effects of an egg production intervention with social behavioral change communication and subsidy on child dietary diversity in Ethiopia. Scientific Reports.

Ahmed, E., Gizaw, G., & Argaw, A. (2025). Association between self-reported sleep quality and body mass index among Jimma University academic staff: Structural equation modeling. BMC Nutrition.

Trehan, I., Beyene, Y., Darsene, H., Adams, B. S., Wrabel, M., Gizaw, G., Legese, L. A., Cichon, B., Chitekwe, S., Shellemew, M. W., et al. (2025). The Modified Dosages for Acute Malnutrition (MODAM) study: Protocol for three integrated randomized controlled trials of novel approaches for the management of childhood wasting in Ethiopia. BMC Nutrition.

Tamiru, D., Girma, S., & Gizaw, G. (2025). Contributing factors to acute malnutrition among children admitted to public health facilities in South West Ethiopia: A matched case–control study. Frontiers in Nutrition.

Gizaw, G., Wells, J. C., Argaw, A., Olsen, M. F., Abdissa, A., Asres, Y., Challa, F., Berhane, M., Abera, M., Sadler, K., et al. (2025). Associations of early childhood exposure to severe acute malnutrition and recovery with cardiometabolic risk markers in later childhood: 5-year prospective matched cohort study in Ethiopia. The American Journal of Clinical Nutrition.

Zhuofeng Lin | Myocardial infarction | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Zhuofeng Lin | Myocardial infarction | Best Researcher Award 

Prof. Dr. Zhuofeng Lin, Guangdong Medical University, China

Prof. Dr. Zhuofeng Lin is the Dean of the Experimental Animal Center and Dean of the Innovational Center of Cardiometabolic Disease at Guangdong Medical University, China. His research focuses on cross-organ communication in cardiovascular and metabolic diseases, particularly the role of metabolic hormones and obesity. He has made significant contributions to understanding FGF21 metabolic regulation, impacting blood glucose stability, blood pressure control, and anti-atherosclerosis therapies. His work also explores new targets for anti-myocardial infarction, heart failure, and vascular calcification drugs, driving innovation in metabolic and cardiovascular medicine. His research is widely recognized in international medical science.

AUTHOR PROFILE

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Dr. Zhuofeng Lin’s academic journey began with a strong foundation in medical sciences, focusing on cardiovascular and metabolic diseases. His early research explored physiological mechanisms and metabolic interactions, leading him to specialize in cross-organ communication and metabolic regulation. His education and initial training laid the groundwork for his extensive contributions to cardiometabolic research.

🏢PROFESSIONAL ENDEAVORS:

Prof. Lin has held prestigious positions at Guangdong Medical University, where he currently serves as:

  • Dean of the Experimental Animal Center 🐁
  • Dean of the Innovational Center of Cardiometabolic Disease 🫀

His leadership in these institutions has driven significant advancements in experimental research methodologies and the development of innovative treatment strategies for metabolic disorders.

🔍CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Prof. Lin’s research is dedicated to practical applications, with a strong emphasis on:

  • Cross-organ communication in cardiovascular and metabolic diseases
  • Pathogenesis of cardiometabolic disorders linked to metabolic hormones and obesity
  • Fibroblast Growth Factor 21 (FGF21) and its role in metabolic regulation

His studies have provided groundbreaking insights into FGF21’s ability to regulate:
✅ Blood glucose levels
✅ Blood pressure stability
✅ Anti-atherosclerosis mechanisms
✅ Anti-Metabolic Dysfunction-Associated Steatohepatitis (MASH) therapies

Additionally, his work focuses on discovering new therapeutic targets for:
⚕️ Anti-myocardial infarction drugs
⚕️ Anti-heart failure treatments
⚕️ Anti-vascular calcification solutions

🌍IMPACT AND INFLUENCE:

Prof. Lin’s research has had a profound impact on global medical science, particularly in the fields of:
🔹 Metabolic disease management
🔹 Cardiovascular treatment innovations
🔹 Therapeutic drug development

His studies have influenced clinical practices, contributing to better patient outcomes in cardiovascular and metabolic health. His pioneering work in hormonal regulation and metabolic stability has inspired numerous scientists and researchers worldwide.

📄ACADEMIC CITES AND RECOGNITION:

Prof. Lin’s research is widely recognized in high-impact medical journals, with numerous citations supporting his theories. His work on FGF21 metabolic regulation is frequently referenced in the fields of endocrinology, cardiology, and metabolic research. He has been a keynote speaker at international medical conferences, sharing his insights with the global scientific community.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

With an unwavering commitment to scientific innovation, Prof. Lin continues to shape the future of medical research. His ongoing projects aim to:
🔬 Develop novel cardiometabolic therapies
🔬 Enhance cross-organ communication research
🔬 Introduce cutting-edge treatments for heart disease and metabolic disorders

His legacy will be defined by his transformative contributions to medicine, paving the way for future breakthroughs in cardiovascular and metabolic health.

💡CONCLUSION:

Prof. Dr. Zhuofeng Lin is a pioneering leader in cardiometabolic research, making groundbreaking contributions to understanding metabolic regulation and cardiovascular health. His work on FGF21 has revolutionized approaches to blood glucose stability, blood pressure control, and anti-atherosclerosis treatments . With a vision for therapeutic innovation, he continues to explore new drug targets for heart failure, myocardial infarction, and vascular calcification . His impact on medical science is profound, shaping the future of metabolic and cardiovascular treatments. His dedication ensures lasting advancements in healthcare and patient well-being.

TOP NOTABLE PUBLICATIONS

Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice

Authors: Z Lin, H Tian, KSL Lam, S Lin, RCL Hoo, M Konishi, N Itoh, Y Wang, …
Journal: Cell Metabolism
Year: 2013

Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice

Authors: Z Lin, X Pan, F Wu, D Ye, Y Zhang, Y Wang, L Jin, Q Lian, Y Huang, …
Journal: Circulation
Year: 2015

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

Authors: Z Lin, Z Wu, X Yin, Y Liu, X Yan, S Lin, J Xiao, X Wang, W Feng, X Li
Journal: PLoS One
Year: 2010

Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues

Authors: L Geng, B Liao, L Jin, Z Huang, CR Triggle, H Ding, J Zhang, Y Huang, …
Journal: Cell Reports
Year: 2019

Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2

Authors: D Ye, K Yang, S Zang, Z Lin, HT Chau, Y Wang, J Zhang, J Shi, A Xu, …
Journal: Journal of Hepatology
Year: 2016

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

Authors: Z Lin, Z Zhou, Y Liu, Q Gong, X Yan, J Xiao, X Wang, S Lin, W Feng, X Li
Journal: PLoS One
Year: 2011

FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1–7) axis in mice

Authors: X Pan, Y Shao, F Wu, Y Wang, R Xiong, J Zheng, H Tian, B Wang, …
Journal: Cell Metabolism
Year: 2018

Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice

Authors: Z Lin, F Wu, S Lin, X Pan, L Jin, T Lu, L Shi, Y Wang, A Xu, X Li
Journal: Journal of Hepatology
Year: 2014

Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K/Akt signaling‐dependent manner

Authors: Y Pan, B Wang, J Zheng, R Xiong, Z Fan, Y Ye, S Zhang, Q Li, F Gong, …
Journal: Journal of Cellular and Molecular Medicine
Year: 2019

Dynamic change of serum FGF21 levels in response to glucose challenge in human

Authors: Z Lin, Q Gong, C Wu, J Yu, T Lu, X Pan, S Lin, X Li
Journal: The Journal of Clinical Endocrinology & Metabolism
Year: 2012

Lingyan Chen | Cardiovascular Diseases | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Lingyan Chen | Cardiovascular Diseases | Best Researcher Award